(Q36478301)

14 August 2017

1 reference

title

Implication of cannabinoids in neurological diseases (English)

1 reference

14 August 2017

0 references

Angela Alsasua del Valle

series ordinal

1

1 reference

14 August 2017

12 May 2006

1 reference

Cellular and Molecular Neurobiology

14 August 2017

1 reference

14 August 2017

26

1 reference

14 August 2017

4-6

1 reference

14 August 2017

579-591

1 reference

https://scigraph.springernature.com/pub.10.1007/s10571-006-9070-8

14 August 2017

0 references

cites work

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study

1 reference

https://api.crossref.org/works/10.1007%2FS10571-006-9070-8

Marijuana use and epilepsy: prevalence in patients of a tertiary care epilepsy center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-006-9070-8

Pharmacological, physiological and clinical implications of the discovery of cannabinoid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-006-9070-8

The endocannabinoid system: physiology and pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-006-9070-8

Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-006-9070-8

Acute neuronal injury, excitotoxicity, and the endocannabinoid system

21 January 2018

1 reference

12 December 2020

Cannabinoids inhibit neurodegeneration in models of multiple sclerosis

1 reference

12 December 2020

Cannabinoids control spasticity and tremor in a multiple sclerosis model

1 reference

12 December 2020

The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects.

1 reference

12 December 2020

Neuroprotection by the cannabinoid agonist WIN-55212 in an in vivo newborn rat model of acute severe asphyxia.

1 reference

12 December 2020

Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity.

1 reference

12 December 2020

Pharmacology of cannabinoid CB1 and CB2 receptors.

1 reference

12 December 2020

The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons

1 reference

12 December 2020

Cannabis and the brain

1 reference

12 December 2020

From cannabis to endocannabinoids in multiple sclerosis: a paradigm of central nervous system autoimmune diseases.

1 reference

12 December 2020

Cannabinoids in clinical practice

1 reference

12 December 2020

Delta 9-tetrahydrocannabinol and cannabinol activate capsaicin-sensitive sensory nerves via a CB1 and CB2 cannabinoid receptor-independent mechanism.

1 reference

12 December 2020

Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis.

1 reference

12 December 2020

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

12 December 2020

The endocannabinoid system as a target for therapeutic drugs.

1 reference

12 December 2020

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

1 reference

12 December 2020

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system

1 reference

12 December 2020

Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease

1 reference

12 December 2020

The quest for a vascular endothelial cannabinoid receptor

1 reference

12 December 2020

Determination and characterization of a cannabinoid receptor in rat brain

1 reference

12 December 2020

The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy

1 reference

12 December 2020

Survey on cannabis use in Parkinson's disease: subjective improvement of motor symptoms

1 reference

12 December 2020

Endocannabinoids control spasticity in a multiple sclerosis model

1 reference

12 December 2020

Discovery and characterization of endogenous cannabinoids

1 reference

12 December 2020

Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars reticulata

1 reference

12 December 2020

A role for cannabinoid CB1 receptors in mood and anxiety disorders

1 reference

12 December 2020

Effects of exogenous and endogenous cannabinoids on GABAergic neurotransmission between the caudate-putamen and the globus pallidus in the mouse

1 reference

12 December 2020

[Therapeutic use of cannabinoids in neurology].

1 reference

12 December 2020

The role of cannabinoids in neurodegenerative diseases

1 reference

12 December 2020

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

12 December 2020

Cannabinoids enhance NMDA-elicited Ca2+ signals in cerebellar granule neurons in culture.

1 reference

12 December 2020

Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures.

1 reference

12 December 2020

Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus.

1 reference

12 December 2020

The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

1 reference

12 December 2020

Cannabinoid-induced presynaptic inhibition of glutamatergic EPSCs in substantia gelatinosa neurons of the rat spinal cord

1 reference

12 December 2020

Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation

1 reference

12 December 2020

Towards cannabis and cannabinoid treatment of multiple sclerosis.

1 reference

12 December 2020

Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries

1 reference

12 December 2020

Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model

1 reference

12 December 2020

The residual neuropsychological effects of cannabis: the current status of research.

1 reference

12 December 2020

Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures.

1 reference

12 December 2020

CB1 cannabinoid receptor signalling in Parkinson's disease

1 reference

12 December 2020

A second endogenous cannabinoid that modulates long-term potentiation

1 reference

12 December 2020

Anandamide suppresses nitric oxide and TNF-alpha responses to Theiler's virus or endotoxin in astrocytes

1 reference

12 December 2020

CB1 cannabinoid receptors and on-demand defense against excitotoxicity

1 reference

12 December 2020

Marijuana for parkinsonian tremor

1 reference

12 December 2020

Cannabinoid effects in basal ganglia in a rat model of Parkinson's disease.

1 reference

12 December 2020

Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease

1 reference

12 December 2020

On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures

1 reference

12 December 2020

In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases

1 reference

12 December 2020

Cannabinoids in multiple sclerosis: do they have a therapeutic role?

1 reference

12 December 2020

Effects of expectancies on subjective responses to oral delta9-tetrahydrocannabinol.

1 reference

12 December 2020

The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease

1 reference

12 December 2020

The dually diagnosed patient with psychotic symptoms

1 reference

12 December 2020

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

12 December 2020

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

12 December 2020

Cannabis in movement disorders

1 reference

12 December 2020

Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons

1 reference

12 December 2020

Axonal damage in acute multiple sclerosis lesions.

1 reference

12 December 2020

Cannabinoids and brain injury: therapeutic implications

1 reference

12 December 2020

Neurons on cannabinoids: dead or alive?

1 reference

12 December 2020

A Total Synthesis of dl-Δ1-Tetrahydrocannabinol, the Active Constituent of Hashish1

1 reference

12 December 2020

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

1 reference

12 December 2020

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

1 reference

12 December 2020

Loss of cannabinoid receptors in the substantia nigra in Huntington's disease.

1 reference

12 December 2020

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

1 reference

12 December 2020

Differential effects of endocannabinoids on [(3)H]-GABA uptake in the rat globus pallidus

1 reference

12 December 2020

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

1 reference

12 December 2020

10.1007/S10571-006-9070-8

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16699878